Kinin B1 receptors as a therapeutic target for inflammation

References

• Gilroy D, De Maeyer R. New insights into the resolution of inflammation. Semin Immunol. 2015;27(3):161–168.
   PubMed Web of Science ®Google Scholar
• Skidgel RA, Erdös EG. Cellular carboxypeptidases. Immunol Rev. 1998;61:129–141.
   Google Scholar
• Bhoola KD, Figueroa CD, Worthy K. Bioregulation of kinins: kallikreins,kininogens, and kininases. Pharmacol Rev. 1992;44(1):1–80.
   PubMed Web of Science ®Google Scholar
• Moreau ME, Garbacki N, Molinaro G, et al. The kallikrein-kinin system: current and future pharmacological targets. J Pharmacol Sci. 2005;99(1):6–38.
   PubMed Web of Science ®Google Scholar
• Pesquero JB, Bader M. Molecular biology of the kallikrein-kinin system: from structure to function. Braz J Med Biol Res. 1998;31:1197–1203.
   PubMed Web of Science ®Google Scholar
• Bader M, Ed.. Kinins, Walter de Gruyter GmbH. Berlin, Germany. 2011.
   Google Scholar
• Hess JF, Borkowski JA, Young GS, et al. Cloning and pharmacological characterization of a human bradykinin (BK-2) receptor. Biochem Biophys Res Commun. 1992;184(1):260–268.
   PubMed Web of Science ®Google Scholar
• Menke JG, Borkowski JA, Bierilo KK, et al. Expression cloning of a human B1 bradykinin receptor. J Biol Chem. 1994;269(34):21583–21586.
   PubMed Web of Science ®Google Scholar
• Shughrue PJ, Ky B, Austin CP. Localization of B1 bradykinin receptor mRNA in the primate brain and spinal cord: an in situ hybridization study. J Comp Neurol. 2003;465(3):372–384.
   PubMed Web of Science ®Google Scholar
• Marceau F, Lussier A, Regoli D, et al. Pharmacology of kinins: their relevance to tissue injury and inflammation. Gen Pharmacol. 1983;14(2):209–229.
   PubMedGoogle Scholar
• Dray A, Perkins M. Bradykinin and inflammatory pain. Trends Neurosci. 1993;16(3):99–104.
   PubMed Web of Science ®Google Scholar
• Couture R, Harrisson M, Vianna RM, et al. Kinin receptors in pain and inflammation. Eur J Pharmacol. 2001;429(1–3):161–176.
   PubMed Web of Science ®Google Scholar
• Walker K, Perkins M, Dray A. Kinins and kinin receptors in the nervous system. Neurochem Int. 1995;26(1):1-16; discussion 17-26.
   PubMedGoogle Scholar
• Wu J, Akaike T, Hayashida K, et al. Identification of bradykinin receptors in clinical cancer specimens and murine tumor tissues. Int J Cancer. 2002;98(1):29–35.
   PubMed Web of Science ®Google Scholar
• Böckmann S, Paegelow I. Kinins and kinin receptors: importance for the activation of leukocytes. J Leukoc Biol. 2000;68(5):587–592.
   PubMed Web of Science ®Google Scholar
• Rochee Silva M, Beraldo WT, et al. Bradykinin, a hypotensive and smooth muscle stimulating factor released from plasma globulin by snake venoms and by trypsin. Am J Physiol. 1949;156(2):261–273.
   PubMedGoogle Scholar
• Holdstock DJ, Mathias AP, Schachter M. A comparative study of kinin, kallidin, and bradykinin. Br J Pharmacol Chemother. 1957;12(2):149–158.
   PubMed Web of Science ®Google Scholar
• Davies GE, Lowe JS. Chemical mediators of inflammation in guinea-pig skin. Trans St Johns Hosp Dermatol Soc. 1962;48:157–162.
   PubMedGoogle Scholar
• Stern P, Nikulin A, Ferluga J. The role of histamine and bradykinin in the inflammatory process. Arch Int Pharmacodyn Ther. 1962;140:528–538.
   PubMedGoogle Scholar
• Lewis GP. Plasma kinins and inflammation. Metabolism. 1964;13:1256–1263.
   Web of Science ®Google Scholar
• Drouin JN, Gaudreau P, St-Pierre S, et al. Biological activities of kinins modified at the N- or at the C-terminal end. Can J Physiol Pharmacol. 1979;57(9):1018–1023.
   PubMed Web of Science ®Google Scholar
• Marceau F, Barabé J, St-Pierre S, et al. Kinin receptors in experimental inflammation. Can J Physiol Pharmacol. 1980;58(5):536–542.
   PubMed Web of Science ®Google Scholar
• Regoli DC, Marceau F, Lavigne J. Induction of beta 1-receptors for kinins in the rabbit by a bacterial lipopolysaccharide. Eur J Pharmacol. 1981;71(1):105–115.
   PubMed Web of Science ®Google Scholar
• Dray A. Kinins and their receptors in hyperalgesia. Can J Physiol Pharmacol. 1997;75(6):704–712.
   PubMed Web of Science ®Google Scholar
• Calixto JB, Medeiros R, Fernandes ES, et al. Kinin B1 receptors: key G-protein-coupled receptors and their role in inflammatory and painful processes. Br J Pharmacol. 2004;143(7):803–818.
   PubMed Web of Science ®Google Scholar
• Leeb-Lundberg LM, Marceau F, Müller-Esterl W, et al. International union of pharmacology. XLV. Classification of the kinin receptor family: from molecular mechanisms to pathophysiological consequences. Pharmacol Rev. 2005;57(1):27–77.
   PubMed Web of Science ®Google Scholar
• Duchene J, Ahluwalia A. The kinin B(1) receptor and inflammation: new therapeutic target for cardiovascular disease. Curr Opin Pharmacol. 2009;9(2):125–131.
   PubMed Web of Science ®Google Scholar
• Couture R, Blaes N, Girolami JP. Kinin receptors in vascular biology and pathology. Curr Vasc Pharmacol. 2014;12(2):223–248.
   PubMed Web of Science ®Google Scholar
• Marceau F. Kinin B1 receptors: a review. Immunopharmacology. 1995;30(1):1–26.
   PubMedGoogle Scholar
• Donaldson LF, Hanley MR, Villablanca AC. Inducible receptors. Trends Pharmacol Sci. 1997;18(5):171–181.
   PubMed Web of Science ®Google Scholar
• Kang DS, Gustafsson C, Mörgelin M, et al. B1 bradykinin receptor homo-oligomers in receptor cell surface expression and signaling: effects of receptor fragments. Mol Pharmacol. 2005;67(1):309–318.
   PubMed Web of Science ®Google Scholar
• Dixon DA, Kaplan CD, McIntyre TM, et al. Post-transcriptional control of cyclooxygenase-2 gene expression. The role of the 3ʹ-untranslated region. J Biol Chem. 2000 21;275(16):11750–11757.
   PubMed Web of Science ®Google Scholar
• Zhou X, Polgar P, Taylor L. Roles for interleukin-1beta, phorbol ester and a post-transcriptional regulator in the control of bradykinin B1 receptor gene expression. Biochem J. 1998. 15. 330(Pt 1):361–366.
   PubMedGoogle Scholar
• Zhou X, Prado GN, Taylor L, et al. Regulation of inducible bradykinin B1 receptor gene expression through absence of internalization and resensitization. J Cell Biochem. 2000;78(3):351–362.
   PubMed Web of Science ®Google Scholar
• Schanstra JP, Bataillé E, Marin Castaño ME, et al. The B1-agonist [des-Arg10]-kallidin activates transcription factor NF-kappaB and induces homologous upregulation of the bradykinin B1-receptor in cultured human lung fibroblasts. J Clin Invest. 1998;101(10):2080–2091.
   PubMed Web of Science ®Google Scholar
• Ni A, Chao L, Chao J. Transcription factor nuclear factor kappaB regulates the inducible expression of the human B1 receptor gene in inflammation. J Biol Chem. 1998;273(5):2784–2791.
   PubMed Web of Science ®Google Scholar
• Sardi SP, Rey-Ares V, Pujol-Lereis VA, et al. Further pharmacological evidence of nuclear factor-kappa B pathway involvement in bradykinin B1 receptor-sensitized responses in human umbilical vein. J Pharmacol Exp Ther. 2002;301(3):975–980.
   PubMed Web of Science ®Google Scholar
• Medeiros R, Cabrini DA, Ferreira J, et al. Bradykinin B1 receptor expression induced by tissue damage in the rat portal vein: a critical role for mitogen-activated protein kinase and nuclear factor-kappaB signaling pathways. Circ Res. 2004 28;94(10):1375–1382.
   PubMed Web of Science ®Google Scholar
• Passos GF, Fernandes ES, Campos MM, et al. Kinin B1 receptor up-regulation after lipopolysaccharide administration: role of proinflammatory cytokines and neutrophil influx. J Immunol. 2004 1;172(3):1839–1847.
   PubMed Web of Science ®Google Scholar
• Merino VF, Silva JA Jr, Araújo RC, et al. Molecular structure and transcriptional regulation by nuclear factor-kappaB of the mouse kinin B1 receptor gene. Biol Chem. 2005;386(6):515–522.
   PubMed Web of Science ®Google Scholar
• Deblois D, Bouthillier J, Marceau F, et al. Effect of glucocorticoids, monoklines and growth factors on the spontaneously developing responses of the rabit isolated aorta to des-Arg9-bradykinin. Br J Pharmacol. 1988;93(4):969–977.
   PubMed Web of Science ®Google Scholar
• Koumbadinga GA, Desormeaux A, Adam A, et al. Effect of interferon-γ on inflammatory cytokine-induced bradykinin B1 receptor expression in human vascular cells. Eur J Pharmacol. 2010;647(1–3):117–125.
   PubMed Web of Science ®Google Scholar
• Campos MM, Souza GE, Calixto JB. Modulation of kinin B1 but not B2 receptors mediated rat paw edema by IL-1beta and TNFalpha. Peptides. 1998;19(7):1269–1276.
   PubMed Web of Science ®Google Scholar
• Marceau F, Bachvarov DR. Kinin receptors. Clin Rev Allergy Immunol. 1998;16(4):385–401.
   PubMed Web of Science ®Google Scholar
• Ghebrehiwet B, Ji Y, Valentino A, et al. Soluble gC1qR is an autocrine signal that induces B1R expression on endothelial cells. J Immunol. 2014;192(1):377–384.
   PubMed Web of Science ®Google Scholar
• Lahti A, Jalonen U, Kankaanranta H, et al. c-Jun NH2-terminal kinase inhibitor anthra(1,9-cd)pyrazol-6(2H)-one reduces inducible nitric-oxide synthase expression by destabilizing mRNA in activated macrophages. Mol Pharmacol. 2003;64(2):308–315.
   PubMed Web of Science ®Google Scholar
• Larrivée JF, Bachvarov DR, Houle F, et al. Role of the mitogen-activated protein kinases in the expression of the kinin B1 receptors induced by tissue injury. J Immunol. 1998;160(3):1419–1426.
   PubMed Web of Science ®Google Scholar
• Zhou X, Prado GN, Chai M, et al. Posttranscriptional destabilization of the bradykinin B1 receptor messenger RNA: cloning and functional characterization of the 3ʹ-untranslated region. Mol Cell Biol Res Commun. 1999;1(1):29–35.
   PubMedGoogle Scholar
• Haddad EB, Fox AJ, Rousell J, et al. Post-transcriptional regulation of bradykinin B1 and B2 receptor gene expression in human lung fibroblasts by tumor necrosis factor-alpha: modulation by dexamethasone. Mol Pharmacol. 2000;57(6):1123–1131.
   PubMed Web of Science ®Google Scholar
• Campos MM, Souza GE, Calixto JB. In vivo B1 kinin-receptor upregulation. Evidence for involvement of protein kinases and nuclear factor kappaB pathways. Br J Pharmacol. 1999;27(8):1851–1859.
   Google Scholar
• Phagoo SB, Reddi K, Anderson KD, et al. Bradykinin B1 receptor up-regulation by interleukin-1beta and B1 agonist occurs through independent and synergistic intracellular signaling mechanisms in human lung fibroblasts. J Pharmacol Exp Ther. 2001;298(1):77–85.
   PubMed Web of Science ®Google Scholar
• Moreau ME, Bawolak MT, Morissette G, et al. Role of nuclear factor-kappaB and protein kinase C signaling in the expression of the kinin B1 receptor in human vascular smooth muscle cells. Mol Pharmacol. 2007;71(3):949–956.
   PubMed Web of Science ®Google Scholar
• Fortin JP, Bouthillier J, Marceau F. High agonist-independent clearance of rabbit B1 receptors on cultured cells. Am J Physiol Heart Cir Physiol. 2003;284:H1647–H1654.
   PubMed Web of Science ®Google Scholar
• Enquist J, Skröder C, Whistler JL, et al. LM. Kinins promote B2 receptor endocytosis and delay constitutive B1 receptor endocytosis. Mol Pharmacol. 2007;71(2):494–507.
   PubMed Web of Science ®Google Scholar
• Kang DS, Ryberg K, Mörgelin M, et al. Spontaneous formation of a proteolytic B1 and B2 bradykinin receptor complex with enhanced signaling capacity. J Biol Chem. 2004 21;279(21):22102–22107.
   PubMed Web of Science ®Google Scholar
• Yanaga F, Hirata M, Koga T. Evidence for coupling of bradykinin receptors to a guanine-nucleotide binding protein to stimulate arachidonate liberation in the osteoblast-like cell line, MC3T3-E1. Biochim Biophys Acta. 1991;1094(2):139–146.
   PubMedGoogle Scholar
• Liao JK, Homcy CJ. The G proteins of the G alpha i and G alpha q family couple the bradykinin receptor to the release of endothelium-derived relaxing factor. J Clin Invest. 1993;92(5):2168–2172.
   PubMed Web of Science ®Google Scholar
• Austin CE, Faussner A, Robinson HE, et al. Stable expression of the human kinin B1 receptor in Chinese hamster ovary cells. Characterization of ligand binding and effector pathways. J Biol Chem. 1997;272(17):11420–11425.
   PubMed Web of Science ®Google Scholar
• Xie P, Browning DD, Hay N, et al. Activation of NF-kappa B by bradykinin through a Galpha(q)- and Gbeta gamma-dependent pathway that involves phosphoinositide 3-kinase and Akt. J Biol Chem. 2000;275(32):24907–24914.
   PubMed Web of Science ®Google Scholar
• Prado GN, Taylor L, Zhou X, et al. Mechanisms regulating the expression, self-maintenance, and signaling-function of the bradykinin B2 and B1 receptors. J Cell Physiol. 2002;193(3):275–286.
   PubMed Web of Science ®Google Scholar
• Mathis SA, Criscimagna NL, Leeb-Lundberg LM. B1 and B2 kinin receptors mediate distinct patterns of intracellular Ca2+ signaling in single cultured vascular smooth muscle cells. Mol Pharmacol. 1996;50(1):128–139.
   PubMed Web of Science ®Google Scholar
• Faussner A, Bathon JM, Proud D. Comparison of the responses of B1 and B2 kinin receptors to agonist stimulation. Immunopharmacology. 1999;45(1–3):13–20.
   PubMedGoogle Scholar
• Marceau F, Sabourin T, Houle S, et al. Kinin receptors: functional aspects. Int Immunopharmacol. 2002;2(13–14):1729–1739.
   PubMed Web of Science ®Google Scholar
• Leeb-Lundberg LM, Kang DS, Lamb ME, et al. The human B1 bradykinin receptor exhibits high ligand-independent, constitutive activity. Roles of residues in the fourth intracellular and third transmembrane domains. J Biol Chem. 2001 23;276(12):8785–8792.
   PubMed Web of Science ®Google Scholar
• Kuhr F, Lowry J, Zhang Y, et al. Differential regulation of inducible and endothelial nitric oxide synthase by kinin B1 and B2 receptors. Neuropeptides. 2010;44(2):145–154.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Brovkovych V, Brovkovych S, et al. Dynamic receptor-dependent activation of inducible nitric-oxide synthase by ERK-mediated phosphorylation of Ser745. J Biol Chem. 2007;282(44):32453–32461.
   PubMed Web of Science ®Google Scholar
• Tropea MM, Gummelt D, Herzig MS, et al. B1 and B2 kinin receptors on cultured rabbit superior mesenteric artery smooth muscle cells: receptor-specific stimulation of inositol phosphate formation and arachidonic acid release by des-Arg9-bradykinin and bradykinin. J Pharmacol Exp Ther. 1993;264(2):930–937.
   PubMed Web of Science ®Google Scholar
• Bascands JL, Pecher C, Girolami JP. Indirect inhibition by bradykinin of cyclic AMP generation in isolated rat glomeruli and mesangial cells. Mol Pharmacol. 1993;44(4):818–826.
   PubMed Web of Science ®Google Scholar
• Christopher J, Velarde V, Jaffa AA. Induction of B(1)-kinin receptors in vascular smooth muscle cells: cellular mechanisms of map kinase activation. Hypertension. 2001;38:602–605.
   PubMed Web of Science ®Google Scholar
• Dixon BS, Evanoff D, Fang WB, et al. Bradykinin B1 receptor blocks PDGF-induced mitogenesis by prolonging ERK activation and increasing p27Kip1. Am J Physiol Cell Physiol. 2002;283(1):C193–203.
   PubMed Web of Science ®Google Scholar
• Ehrenfeld P, Matus CE, Pavicic F, et al. Kinin B1 receptor activation turns on exocytosis of matrix metalloprotease-9 and myeloperoxidase in human neutrophils: involvement of mitogen-activated protein kinase family. J Leukoc Biol. 2009;86(5):1179–1189.
   PubMed Web of Science ®Google Scholar
• Duchene J, Lecomte F, Ahmed S, et al. A novel inflammatory pathway involved in leukocyte recruitment: role for the kinin B1 receptor and the chemokine CXCL5. J Immunol. 2007;179(7):4849–4856.
   PubMed Web of Science ®Google Scholar
• Zhang X, Tan F, Skidgel RA. Carboxypeptidase M is a positive allosteric modulator of the kinin B1 receptor. J Biol Chem. 2013;288(46):33226–33240.
   PubMed Web of Science ®Google Scholar
• Regoli D, Nsa Allogho S, Rizzi A, et al. Bradykinin receptors and their antagonists. Eur J Pharmacol. 1998;348(1):1–10.
   PubMed Web of Science ®Google Scholar
• Hess JF, Hey PJ, Chen TB, et al. Molecular and pharamacological diversity of the kinin B1 receptor. Int Immunopharmacol. 2002;2(13–14):1747–1754.
   PubMed Web of Science ®Google Scholar
• Pesquero JB, Bader M. Genetically altered animal models in the kallikrein-kinin system. Biol Chem. 2006;387(2):119–126.
   PubMed Web of Science ®Google Scholar
• Regoli D, Barabé J. Pharmacology of bradykinin and related kinins. Pharmacol Rev. 1980;32(1):1–46.
   PubMed Web of Science ®Google Scholar
• Gobeil F, Neugebauer W, Filteau C, et al. Structure-activity studies of B1 receptor-related peptides. Antagonists Hypertension. 1996;28(5):833–839.
   PubMed Web of Science ®Google Scholar
• Stewart JM, Gera L, Hanson W, et al. A new generation of bradykinin antagonists. Immunopharmacology. 1996;33(1–3):51–60.
   PubMedGoogle Scholar
• Gobeil F Jr, Sirois P, Regoli D. Preclinical pharmacology, metabolic stability, pharmacokinetics and toxicology of the peptidic kinin B1 receptor antagonist R-954. Peptides. 2014;52:82–89.
   PubMed Web of Science ®Google Scholar
• Fincham CI, Bressan A, Paris M, et al. Bradykinin receptor antagonists–a review of the patent literature 2005-2008. Expert Opin Ther Pat. 2009;19(7):919–941.
   PubMed Web of Science ®Google Scholar
• Huang H, Player MR. Bradykinin B1 receptor antagonists as potential therapeutic agents for pain. J Med Chem. 2010;53(15):5383–5399.
   PubMed Web of Science ®Google Scholar
• Bozó É, Éles J, Keserű GM. Bradykinin B1 receptor antagonists: a patent update 2009-2012. Expert Opin Ther Pat. 2012;22(12):1443–1452.
   PubMed Web of Science ®Google Scholar
• Gougat J, Ferrari B, Sarran L, et al. SSR240612 [(2R)-2-[((3R)-3-(1,3-benzodioxol-5-yl)-3-[[(6-methoxy-2-naphthyl)sulfonyl]amino] propanoyl)amino]-3-(4-[[2R,6S)-2,6-dimethylpiperidinyl]methyl]phenyl)-N-isopropyl -N-methylpropanamide hydrochloride], a new nonpeptide antagonist of the bradykinin B1 receptor: biochemical and pharmacological characterization. J Pharmacol Exp Ther. 2004;309(2):661–669.
   PubMed Web of Science ®Google Scholar
• Porreca F, Vanderah TW, Guo W, et al. Antinociceptive pharmacology of N-[[4-(4,5-dihydro-1H-imidazol-2-yl)phenyl]methyl]-2-[2-[[(4-methoxy-2,6-dimethyl phenyl) sulfonyl]methylamino]ethoxy]-N-methylacetamide, fumarate (LF22-0542), a novel nonpeptidic bradykinin B1 receptor antagonist. J Pharmacol Exp Ther. 2006;318(1):195–205.
   PubMed Web of Science ®Google Scholar
• Barth M, Bondoux M, Luccarini JM, et al. From bradykinin B2 receptor antagonists to orally active and selective bradykinin B1 receptor antagonists. J Med Chem. 2012;55(6):2574–2584.
   PubMed Web of Science ®Google Scholar
• Pouliot M, Talbot S, Sénécal J, et al. Ocular application of the kinin B1 receptor antagonist LF22-0542 inhibits retinal inflammation and oxidative stress in streptozotocin-diabetic rats. PLoS One. 2012;7(3):e33864.
   PubMed Web of Science ®Google Scholar
• Kuduk SD, Di Marco CN, Chang RK, et al. Development of orally bioavailable and CNS penetrant biphenylaminocyclopropane carboxamide bradykinin B1 receptor antagonists. J Med Chem. 2007 25;50(2):272–282.
   PubMed Web of Science ®Google Scholar
• Feng DM, DiPardo RM, Wai JM, et al. A new class of bradykinin B1 receptor antagonists with high oral bioavailability and minimal PXR activity. Bioorg Med Chem Lett. 2008 15;18(2):682–687.
   PubMed Web of Science ®Google Scholar
• Kuduk SD, Bock MG. Bradykinin B1 receptor antagonists as novel analgesics: a retrospective of selected medicinal chemistry developments. Curr Top Med Chem. 2008;8(16):1420–1430.
   PubMed Web of Science ®Google Scholar
• Tang C, Carr BA, Poignant F, et al. CYP2C75-involved autoinduction of metabolism in rhesus monkeys of methyl 3-chloro-3ʹ-fluoro-4ʹ-{(1R)-1-[({1-[(trifluoroacetyl)amino]cyclopropyl}carbonyl)a mino]ethyl}-1,1ʹ-biphenyl-2-carboxylate (MK-0686), a bradykinin B1 receptor antagonist. J Pharmacol Exp Ther. 2008;325(3):935–946.
   PubMed Web of Science ®Google Scholar
• D’Amico DC, Aya T, Human J, et al. Identification of a nonpeptidic and conformationally restricted bradykinin B1 receptor antagonist with anti-inflammatory activity. J Med Chem. 2007 22;50(4):607–610.
   PubMed Web of Science ®Google Scholar
• Biswas K, Li A, Chen JJ, et al. Potent nonpeptide antagonists of the bradykinin B1 receptor: structure-activity relationship studies with novel diaminochroman carboxamides. J Med Chem. 2007 3;50(9):2200–2212.
   PubMed Web of Science ®Google Scholar
• Biswas K, Aya T, Qian W, et al. Aryl sulfones as novel bradykinin B1 receptor antagonists for treatment of chronic pain. Bioorg Med Chem Lett. 2008 1;18(17):4764–4769.
   PubMed Web of Science ®Google Scholar
• Chen JJ, Qian W, Biswas K, et al. Discovery of dihydroquinoxalinone acetamides containing bicyclic amines as potent Bradykinin B1 receptor antagonists. Bioorg Med Chem Lett. 2008;18(16):4477–4481.
   PubMed Web of Science ®Google Scholar
• Doods H, Hauel N, Kirsten A, et al. BI 113823, a novel B1 receptor antagonist exhibiting antinociceptive properties in inflammatory pain models. Pain Practice. 2012;12:18.
   Google Scholar
• Ritchie TJ, Dziadulewicz EK, Culshaw AJ, et al. Potent and orally bioavailable non-peptide antagonists at the human bradykinin B(1) receptor based on a 2-alkylamino-5-sulfamoylbenzamide core. J Med Chem. 2004 9;47(19):4642–4644.
   PubMed Web of Science ®Google Scholar
• Fox A, Kaur S, Li B, et al. Antihyperalgesic activity of a novel nonpeptide bradykinin B1 receptor antagonist in transgenic mice expressing the human B1 receptor. Br J Pharmacol. 2005;144(7):889–899.
   PubMed Web of Science ®Google Scholar
• Eles J, Beke G, Vágó I, et al. Quinolinyl- and phenantridinyl-acetamides as bradykinin B1 receptor antagonists. Bioorg Med Chem Lett. 2012;22(9):3095–3099.
   PubMed Web of Science ®Google Scholar
• Schaudt M, Locardi E, Zischinsky G, et al. Novel small molecule bradykinin B1 receptor antagonists. Part 1: benzamides and semicarbazides. Bioorg Med Chem Lett. 2010;20(3):1225–1228.
   PubMed Web of Science ®Google Scholar
• Zischinsky G, Stragies R, Schaudt M, et al. Novel small molecule bradykinin B1 receptor antagonists. Part 2: 5-membered diaminoheterocycles. Bioorg Med Chem Lett. 2010;20(3):1229–1232.
   PubMed Web of Science ®Google Scholar
• Schnatbaum K, Schaudt M, Stragies R, et al. Novel small molecule bradykinin B1 receptor antagonists. Part 3: hydroxyurea derivatives. Bioorg Med Chem Lett. 2010;20(3):1233–1236.
   PubMed Web of Science ®Google Scholar
• Horlick RA, Ohl1meyer MH, Stroke IL, et al. Small molecule antagonists of the bradykinin B1 receptor. Immunopharmacology. 1999;43(2–3):169–177.
   PubMed Web of Science ®Google Scholar
• Guo Q, Chandrasekhar J, Ihle D, et al. 1-Benzylbenzimidazoles: the discovery of a novel series of bradykinin B(1) receptor antagonists. Bioorg Med Chem Lett. 2008 15;18(18):5027–5031.
   PubMed Web of Science ®Google Scholar
• Hawkinson JE, Szoke BG, Garofalo AW, et al. Pharmacological, pharmacokinetic, and primate analgesic efficacy profile of the novel bradykinin B1 Receptor antagonist ELN441958. J Pharmacol Exp Ther. 2007;322(2):619–630.
   PubMed Web of Science ®Google Scholar
• Catanzaro OL, Dziubecki D, Obregon P, et al. Antidiabetic efficacy of bradykinin antagonist R-954 on glucose tolerance test in diabetic type 1 mice. Neuropeptides. 2010;44(2):187–189.
   PubMed Web of Science ®Google Scholar
• Tidjane N, Gaboury L, Couture R. Cellular localisation of the kinin B1R in the pancreas of streptozotocin-treated rat and the anti-diabetic effect of the antagonist SSR240612. Biol Chem. 2016;397(4):323–336.
   PubMed Web of Science ®Google Scholar
• Gabra BH, Sirois P. Beneficial effect of chronic treatment with the selective bradykinin B1 receptor antagonists, R-715 and R-954, in attenuating streptozotocin-diabetic thermal hyperalgesia in mice. Peptides. 2003;24(8):1131–1139.
   PubMed Web of Science ®Google Scholar
• Gabra BH, Sirois P. Hyperalgesia in non-obese diabetic (NOD) mice: a role for the inducible bradykinin B1 receptor. Eur J Pharmacol. 2005. 2. 514(1):61–67.
   PubMed Web of Science ®Google Scholar
• Lawson SR, Gabra BH, Nantel F, et al. Effects of a selective bradykinin B1 receptor antagonist on increased plasma extravasation in streptozotocin-induced diabetic rats: distinct vasculopathic profile of major keyorgans. Eur J Pharmacol. 2005 2;514(1):69–78.
   PubMed Web of Science ®Google Scholar
• Kakiko M, Sullivan KA, Bakus C, et al. Lack of both bradykinin B1 and B2 receptors enhances nephropathy, neurophathy, and bone mineral loss in Akita diabetic mice. Proc Natl Acad Sci. 2010;107(22):10190–10195.
   PubMed Web of Science ®Google Scholar
• Pouliot M, Hétu S, Lahjouji K, et al. Modulation of retinal blood flow by kinin B₁ receptor in Streptozotocin-diabetic rats. Exp Eye Res. 2011;92(6):482–489.
   PubMed Web of Science ®Google Scholar
• Catanzaro O, Capponi JA, Michieli J, et al. Bradykinin B₁ antagonism inhibits oxidative stress and restores Na+K+ ATPase activity in diabetic rat peripheral nervous system. Peptides. 2013;44:100–104.
   PubMed Web of Science ®Google Scholar
• Westermann D, Walther T, Savvatis K, et al. Gene deletion of the kinin receptor B1 attenuates cardiac inflammation and fibrosis during the development of experimental diabetic cardiomyopathy. Diabetes. 2009;58(6):1373–1381.
   PubMed Web of Science ®Google Scholar
• Mori MA, Sales VM, Motta FL, et al. Kinin B1 receptor in adipocytes regulates glucose tolerance and predisposition to obesity. PLoS One. 2012;7(9):e44782.
   PubMed Web of Science ®Google Scholar
• Mori MA, Araújo RC, Reis FC, et al. Kinin B1 receptor deficiency leads to leptin hypersensitivity and resistance to obesity. Diabetes. 2008;57(6):1491–1500.
   PubMed Web of Science ®Google Scholar
• Mori MA, Araújo RC, Pesquero JB. Kinin B1 receptor stimulation modulates leptin homeostasis. Evidence for an insulin-dependent mechanism. Int Immunopharmacol. 2008;8(2):242–246.
   PubMed Web of Science ®Google Scholar
• Fonseca RG, Sales VM, Ropelle E, et al. Lack of kinin B₁ receptor potentiates leptin action in the liver. J Mol Med (Berl). 2013;91(7):851–860.
   PubMed Web of Science ®Google Scholar
• Talbot S, Dias JP, El Midaoui A, et al. Beneficial effects of kinin B1 receptor antagonism on plasma fatty acid alterations and obesity in Zucker diabetic fatty rats. Can J Physiol Pharmacol. 2016;94(7):752–757.
   PubMed Web of Science ®Google Scholar
• Kuebler JF, Schremmer-Danninger E, et al. Kinin-B1 receptors in ischaemia-induced pancreatitis: functional importance and cellular localisation. Biol Chem. 2003;384(9):1311–1319.
   PubMed Web of Science ®Google Scholar
• Lacoste B, Tong XK, Lahjouji K, et al. Cognitive and cerebrovascular improvements following kinin B1 receptor blockade in Alzheimer’s disease mice. J Neuroinflammation. 2013;10:57.
   PubMed Web of Science ®Google Scholar
• Amaral FA, Lemos MT, Dong KE, et al. Participation of kinin receptors on memory impairment after chronic infusion of human amyloid-beta 1-40 peptide in mice. Neuropeptides. 2010;44(2):93–97.
   PubMed Web of Science ®Google Scholar
• Prediger RD, Medeiros R, Pandolfo P, et al. Genetic deletion or antagonism of kinin B(1) and B(2) receptors improves cognitive deficits in a mouse model of Alzheimer’s disease. Neuroscience. 2008;151(3):631–643.
   PubMed Web of Science ®Google Scholar
• Passos GF, Medeiros R, Cheng D, et al. The bradykinin B1 receptor regulates Aβ deposition and neuroinflammation in Tg-SwD1 mice. Am J Pathol. 2013;182(5):1740–1749.
   PubMed Web of Science ®Google Scholar
• Dong-Creste KE, Baraldi-Tornisielo T, et al. Kinin B1 receptor mediates memory impairment in the rat hippocampus. Biol Chem. 2016;397(4):353–364.
   PubMed Web of Science ®Google Scholar
• Albert-Weissenberger C, Stetter C, Meuth SG, et al. Blocking of bradykinin receptor B1 protects from focal closed head injury in mice by reducing axonal damage and astroglia activation. J Cereb Blood Flow Metab. 2012;32(9):1747–1756.
   PubMed Web of Science ®Google Scholar
• Trabold R, Erös C, Zweckberger K, et al. The role of bradykinin B(1) and B(2) receptors for secondary brain damage after traumatic brain injury in mice. J Cereb Blood Flow Metab. 2010;30(1):130–139.
   PubMed Web of Science ®Google Scholar
• Liu Y, Liu J, Li M, et al. The effect of kinin B1 receptor on chronic itching sensitization. Mol Pain. 2015 14(11):70.
   Google Scholar
• Feng J, Chen Y, Xiong J, et al. The kinin B1 receptor mediates alloknesis in a murine model of inflammation. Neurosci Lett. 2014;560:31–35.
   PubMed Web of Science ®Google Scholar
• Liang J, He Y, Ji W. Bradykinin-evoked scratching responses in complete Freund’s adjuvant-inflamed skin through activation of B1 receptor. Exp Biol Med (Maywood). 2012;237(3):318–326.
   PubMed Web of Science ®Google Scholar
• Pietrovski EF, Paludo KS, Mendes DA, et al. B1 and B2 kinin receptor participation in hyperproliferative and inflammatory skin processes in mice. J Dermatol Sci. 2011;64(1):23–30.
   PubMed Web of Science ®Google Scholar
• Soley Bda S, Morais RL, Pesquero JB, et al. Kinin receptors in skin wound healing. J Dermatol Sci. 2016;82(2):95–105.
   PubMed Web of Science ®Google Scholar
• Pietrovski EF, Otuki MF, Regoli D, et al. The non-peptide kinin receptor antagonists FR 173657 and SSR 240612: preclinical evidence for the treatment of skin inflammation. Regul Pept. 2009;152(1–3):67–72.
   PubMedGoogle Scholar
• Gonçalves-Zillo TO, Pugliese LS, Sales VM, et al. Increased bone loss and amount of osteoclasts in kinin B1 receptor knockout mice. J Clin Periodontol. 2013;40(7):653–660.
   PubMed Web of Science ®Google Scholar
• Kaufman GN, Zaouter C, Valteau B, et al. Nociceptive tolerance is improved by bradykinin receptor B1 antagonism and joint morphology is protected by both endothelin type A and bradykinin receptor B1 antagonism in a surgical model of osteoarthritis. Arthritis Res Ther. 2011;13(3):R76.
   PubMed Web of Science ®Google Scholar
• Cignachi NP, Pesquero JB, Oliveira RB, et al. Kinin B1 receptor deletion affects bone healing in type 1 diabetic mice. J Cell Physiol. 2015;230(12):3019–3028.
   PubMed Web of Science ®Google Scholar
• Silva CR, Oliveira SM, Hoffmeister C, et al. The role of kinin B1 receptor and the effect of angiotensin I-converting enzyme inhibition on acute gout attacks in rodents. Ann Rheum Dis. 2016;75(1):260–268.
   PubMed Web of Science ®Google Scholar
• Klein J, Gonzalez J, Decramer S, et al. Blockade of the kinin B1 receptor ameloriates glomerulonephritis. J Am Soc Nephrol. 2010;21(7):1157–1164.
   PubMed Web of Science ®Google Scholar
• Klein J, Gonzalez J, Duchene J, et al. Delayed blockade of the kinin B1 receptor reduces renal inflammation and fibrosis in obstructive nephropathy. Faseb J. 2009;23(1):134–142.
   PubMed Web of Science ®Google Scholar
• Wang PH, Cenedeze MA, Campanholle G, et al. Deletion of bradykinin B1 receptor reduces renal fibrosis. Int Immunopharmacol. 2009;9(6):653–657.
   PubMed Web of Science ®Google Scholar
• Estrela GR, Wasinski F, Almeida DC, et al. Kinin B1 receptor deficiency attenuates cisplatin-induced acute kidney injury by modulating immune cell migration. J Mol Med (Berl). 2014;92(4):399–409.
   PubMed Web of Science ®Google Scholar
• Wang PH, Campanholle G, Cenedeze MA, et al. Bradykinin [corrected] B1 receptor antagonism is beneficial in renal ischemia-reperfusion injury. PLoS One. 2008;3(8):e3050.
   PubMed Web of Science ®Google Scholar
• Westermann D, Lettau O, Sobirey M, et al. Doxorubicin cardiomyopathy-induced inflammation and apoptosis are attenuated by gene deletion of the kinin B1 receptor. Biol Chem. 2008;389(6):713–718.
   PubMed Web of Science ®Google Scholar
• Sainz IM, Pixley RA, Colman RW. Fifty years of research on the plasma kallikrein-kinin system: from protein structure and function to cell biology and in-vivo pathophysiology. Thromb Haemost. 2007;98(1):77–83.
   PubMed Web of Science ®Google Scholar
• Kontos MA, Maghee JH, Shapiro W. General and regional circulation effects of synthetic bradykinin in man. Circ Res. 1964;14:352.
   Web of Science ®Google Scholar
• McLean PG, Perretti M, Ahluwalia A. Inducible expression of the kinin B1 receptor in the endotoxemic heart: mechanisms of des-Arg9bradykinin-induced coronary vasodilation. Br J Pharmacol. 1999;128(2):275–282.
   PubMed Web of Science ®Google Scholar
• Robinson JA, Klondnycky ML, Loeb HS, et al. Endotoxin, prekallikrein, complement and systemic vascular resistance. Sequential measurements in man. Am J Med. 1975;59(1):61–67.
   PubMed Web of Science ®Google Scholar
• O’Donnnell TFJ, Clowes GHJ, Talamo RC. Colman RW: kinin activation in the blood of patients with sepsis. Surg Gynecol Obstet. 1976;143:539–545.
   PubMedGoogle Scholar
• Aasen AO, Erichsen NS, Gallimore MJ, et al. Studies on components of the plasma kallikrein-kinin system in plasma samples from normal individuals and patients with septic shock. Adv Shock Res. 1980;4:1–10.
   PubMedGoogle Scholar
• Martínez-Brotóns F, Oncins JR, Mestres J, et al. Plasma kallikrein-kinin system in patients with uncomplicated sepsis and septic shock–comparison with cardiogenic shock. Thromb Haemost. 1987;58(2):709–713.
   PubMed Web of Science ®Google Scholar
• Miyamoto M, Sudo T, Kawamura M, et al. Changes of the kallikrein-kinin system in acute phase of hemorrhagic and septic shock. Nihon Geka Hokan. 1989;58(6):475–484.
   PubMedGoogle Scholar
• Bawolak MT, Touzin K, Moreau ME, et al. Cardiovascular expression of inflammatory signaling moleculaes, the kinin B1 receptor and COX2, in the rabbit: effects of LPS, anti-inflammatory and anti-hypertensive drugs. Regul Pept. 2008;146(1–3):157–168.
   PubMedGoogle Scholar
• Schremmer-Danninger E, Offner A, Siebeck M, et al. B1 bradykinin receptors and carboxypeptidase M are both upregulated in the aorta of pigs after LPS infusion. Biochem Biophys Res Commun. 1998;243(1):246–252.
   PubMed Web of Science ®Google Scholar
• Marin-Castaño ME, Schanstra JP, Praddaude F, et al. Differential induction of functional B1-bradykinin receptors along the rat nephron in endotoxin induced inflammation. Kidney Int. 1998;54(6):1888–1898.
   PubMed Web of Science ®Google Scholar
• Seguin T, Buleon M, Destrube M, et al. Hemodynamic and renal involvement of B1 and B2 kinin receptors during the acute phase of endotoxin shock in mice. Int Immunopharmacol. 2008;8(2):217–221.
   PubMed Web of Science ®Google Scholar
• Bascands JL, Bachvarova M, Neau E, et al. Molecular determinants of LPS-induced acute renal inflammation: implication of the kinin B1 receptor. Biochem Biophys Res Commun. 2009;386(2):407–412.
   PubMed Web of Science ®Google Scholar
• Fischer LG, Hollmann MW, Horstman DJ, et al. Cyclooxygenase inhibitors attenuate bradykinin-induced vasoconstriction in septic isolated rat lungs. Anesth Analg. 2000;90(3):625–631.
   PubMed Web of Science ®Google Scholar
• Viana AF, Maciel IS, Dornelles FN, et al. Kinin B1 receptors mediate depression-like behavior response in stressed mice treated with systemic E. coli lipopolysaccharide. J Neuroinflammation. 2010;31(7):98.
   Google Scholar
• Qadri F, Rimmele F, Mallis L, et al. Acute hypothalamo-pituitary-adrenal axis response to LPS-induced endotoxemia: expression pattern of kinin type B1 and B2 receptors. Biol Chem. 2016 1;397(2):97–109.
   PubMed Web of Science ®Google Scholar
• Pesquero JB, Araujo RC, Heppenstall PA, et al. Hypoalgesia and altered inflammatory responses in mice lacking kinin B1 receptors. Proc Natl Acad Sci U S A. 2000;97(14):8140–8145.
   PubMed Web of Science ®Google Scholar
• Merino VF, Todiras M, Campos LA, et al. Increased susceptibility to endotoxic shock in transgenic rats with endothelial overexpression of kinin B(1) receptors. J Mol Med (Berl). 2008;86(7):791–798.
   PubMed Web of Science ®Google Scholar
• Cayla C, Todiras M, Iliescu R, et al. Mice deficient for both kinin receptors are normotensive and protected from endotoxin-induced hypotension. Faseb J. 2007;21(8):1689–1698.
   PubMed Web of Science ®Google Scholar
• Tidjane N, Hachem A, Zaid Y, et al. A Primary role for kinin B1 receptor in inflammation, organ damage, and lethal thrombosis in a rat model of spetic shock in diabetes. Eur J Inflamm. 2015;13(1):40–52.
   PubMed Web of Science ®Google Scholar
• Murugesan P, Jung B, Lee D, et al. Kinin B1 receptor inhibition with BI113823 reduces inflammatory response, mitigates organ injury, and improves survival among rats with severe sepsis. J Infect Dis. 2016;213(4):532–540.
   PubMed Web of Science ®Google Scholar
• Wheeler AP, Bernard GR. Acute lung injury and the acute respiratory distress syndrome: a clinical review. Lancet. 2007;369(9572):1553–1564.
   PubMed Web of Science ®Google Scholar
• Matthay MA, McAuley DF, Ware LB. Clinical trials in acute respiratory distress syndrome: challenges and opportunities. Lancet Respir Med. 2017;5(6):524–534.
   PubMed Web of Science ®Google Scholar
• Hillmeister P, Persson PB. The Kallikrein-Kinin system. Acta Physiol (Oxf). 2012;206(4):215–219.
   PubMed Web of Science ®Google Scholar
• Campanholle G, Landgraf RG, Borducchi E, et al. Bradykinin inducible receptor is essential to lipopolysaccharide-induced acute lung injury in mice. Eur J Pharmacol. 2010;634(1–3):132–137.
   PubMed Web of Science ®Google Scholar
• Nasseri S, Gurusamy M, Jung B, et al. Kinin B1 receptor antagonist BI113823 reduces acute lung injury. Crit Care Med. 2015;43(11):e499–507.
   PubMed Web of Science ®Google Scholar
• Gurusamy M, Nasseri S, Lee H, et al. Kinin B1 receptor antagonist BI113823 reduces allergen-induced airway inflammation and mucus secretion in mice. Pharmacol Res. 2016;104:132–139.
   PubMed Web of Science ®Google Scholar
• Christiansen SC, Eddleston J, Woessner KM, et al. Up-regulation of functional kinin B1 receptors in allergic airway inflammation. J Immunol. 2002;169(4):2054–2060.
   PubMed Web of Science ®Google Scholar
• Huang TJ, Haddad EB, Fox AJ, et al. Contribution of bradykinin B(1) and B(2) receptors in allergen-induced bronchial hyperresponsiveness. Am J Respir Crit Care Med. 1999;160:1717–1723.
   PubMed Web of Science ®Google Scholar
• Eric J, Bkaily G, Bkaily GB, et al. Des-Arg9-bradykinin increases intracellular Ca2+ in bronchoalveolar eosinophils from ovalbumin-sensitized and -challenged mice. Eur J Pharmacol. 2003;475(1–3):129–137.
   PubMed Web of Science ®Google Scholar
• Pereira RL, Buscariollo BN, Corrêa-Costa M, et al. Bradykinin receptor 1 activation exacerbates experimental focal and segmental glomerulosclerosis. Kidney Int. 2011;79:1217–1227.
   PubMed Web of Science ®Google Scholar
• Kahn R, Mossberg M, Ståhl AL, et al. Microvesicle transfer of kinin B1-receptors is a novel inflammatory mechanism in vasculitis. Kidney Int. 2017;91(1):96–105.
   PubMed Web of Science ®Google Scholar
• Tharaux PL, Dhaun N. Endothelium-Neutrophil Communication via B1-Kinin Receptor-Bearing Microvesicles in Vasculitis. J Am Soc Nephrol. 2017;28(8):2255–2258.
   PubMed Web of Science ®Google Scholar
• Dutra RC. Kinin receptors: key regulators of autoimmunity. Autoimmun Rev. 2017;16(2):192–207.
   PubMed Web of Science ®Google Scholar
• Balagué C, Kunkel SL, Godessart N. Understanding autoimmune disease: new targets for drug discovery. Drug Discov Today. 2009;14(19–20):926–934.
   PubMed Web of Science ®Google Scholar
• Ellis JS, Braley-Mullen H. Mechanisms by which B cells and regulatory T cells influence development of murine organ-specific autoimmune diseases. J Clin Med. 2017;6(2):pii: E13.
   PubMed Web of Science ®Google Scholar
• Germain L, Barabe J, Galeano C. Increased blood concentration of des-Arg9-bradykinin in experimental allergic encephalomyelitis. J Neurol Sci. 1988;83(2–3):211–217.
   PubMed Web of Science ®Google Scholar
• Schulze-Topphoff U, Prat A, et al. Activation of kinin receptor B1 limits encephalitogenic T lymphocyte recruitment to the central nervous system. Nat Med. 2009;15(7):788–793.
   PubMed Web of Science ®Google Scholar
• Bachvarov DR, Landry M, Houle S, et al. Altered frequency of a promoter polymorphic allele of the kinin B1 receptor gene in inflammatory bowel disease. Gastroenterology. 1998;115(5):1045–1048.
   PubMed Web of Science ®Google Scholar
• Hara DB, Leite DF, Fernandes ES, et al. The relevance of kinin B1 receptor upregulation in a mouse model of colitis. Br J Pharmacol. 2008;154(6):1276–1286.
   PubMed Web of Science ®Google Scholar
• Marceau F, Regoli D. Therapeutic options in inflammatory bowel disease: experimentalevidence of a beneficial effect of kinin B1 receptor blockade. Br J Pharmacol. 2008;154(6):1163–1165.
   PubMed Web of Science ®Google Scholar
• Simard B, Gabra BH, Sirois P. Inhibitory effect of a novel bradykinin B1 receptor antagonist, R-954, on enhanced vascular permeability in type 1 diabetic mice. Can J Physiol Pharmacol. 2002;80(12):1203–1207.
   PubMed Web of Science ®Google Scholar
• Qadri F, Stark E, Häuser W, et al. Expression of kinin receptor mRNA in the HPA axis of type 1 and type 2 diabetic rats. Int Immunopharmacol. 2004;4(4):571–576.
   PubMed Web of Science ®Google Scholar
• Gabra BH, Berthiaume N, Sirois P, et al. The kinin system mediates hyperalgesia through the inducible bradykinin B1 receptor subtype: evidencein various experimental animal models of type 1 and type 2 diabetic neuropathy. Biol Chem. 2006;387(2):127–143.
   PubMed Web of Science ®Google Scholar
• Fukata M, Yokoi N, Fukata Y. Neurobiology of autoimmune encephalitis. Curr Opin Neurobiol. 2017;19(48):1–8.
   Google Scholar
• Prat A, Weinrib L, Becher B, et al. Bradykinin B1 receptor expression and function on T lymphocytes in active multiple sclerosis. Neurology. 1999;53(9):2087–2092.
   PubMed Web of Science ®Google Scholar
• Göbel K, Pankratz S, Schneider-Hohendorf T, et al. Blockade of the kinin receptor B1 protects from autoimmune CNS disease by reducing leukocyte trafficking. J Autoimmun. 2011;36(2):106–114.
   PubMed Web of Science ®Google Scholar
• Dutra RC, Leite DF, Bento AF, et al. The role of kinin receptors in preventing neuroinflammation and its clinical severity during experimental autoimmune encephalomyelitis in mice. PLoS One. 2011;6(11):e27875.
   PubMed Web of Science ®Google Scholar
• Dutra RC, Moreira EL, Alberti TB, et al. Spatial reference memory deficits precede motor dysfunction in an experimental autoimmune encephalomyelitis model: the role of kallikrein-kinin system. Brain Behav Immun. 2013;33:90–101.
   PubMed Web of Science ®Google Scholar
• Lin KS, Pan J, Amouroux G, et al. In vivo radioimaging of bradykinin receptor b1, a widely overexpressed molecule in human cancer. Cancer Res. 2015;75(2):387–393.
   PubMed Web of Science ®Google Scholar
• Stewart JM. Bradykinin antagonists as anti-cancer agents. Curr Pharm Des. 2003;9(25):2036–2042.
   PubMed Web of Science ®Google Scholar
• Mahabeer R, Bhoola KD. Kallikrein and kinin receptor genes. Pharmacol Ther. 2000;88(1):77–89.
   PubMed Web of Science ®Google Scholar
• Figueroa CD, Ehrenfeld P, Bhoola KD. Kinin receptors as targets for cancer therapy. Expert Opin Ther Targets. 2012;16(3):299–312.
   PubMed Web of Science ®Google Scholar
• Nicoletti NF, Erig TC, Zanin RF, et al. Mechanisms involved in kinin-induced glioma cells proliferation: the role ofERK1/2 and PI3K/Akt pathways. J Neurooncol. 2014;120(2):235–244.
   PubMed Web of Science ®Google Scholar
• Da Costa PL, Sirois P, Tannock IF, et al. The role of kinin receptors in cancer and therapeutic opportunities. Cancer Lett. 2014;345(1):27–38.
   PubMed Web of Science ®Google Scholar
• Dlamini Z, Bhoola KD. Upregulation of tissue kallikrein, kinin B1 receptor, and kinin B2 receptor in mast and giant cells infiltrating oesophageal squamous cell carcinoma. J Clin Pathol. 2005;58(9):915–922.
   PubMed Web of Science ®Google Scholar
• Toledo C, Matus CE, Barraza X, et al. Expression of HER2 and bradykinin B1 receptors in precursor lesions of gallbladder carcinoma. World J Gastroenterol. 2012;18(11):1208–1215.
   PubMed Web of Science ®Google Scholar
• Zelawski W, Machnik G, Nowaczyk G, et al. Expression and localisation of kinin receptors in colorectal polyps. Int Immunopharmacol. 2006;6(6):997–1002.
   PubMed Web of Science ®Google Scholar
• Wang DC, Plante K, Stewart T, et al. Comparison of survival for partial vs. radical nephrectomy in young patients with T1a renal cell carcinoma treated at commission on cancer-accredited facilities and influence of comorbidities on treatment choice. Urol Oncol. 2017;20:pii: S1078-1439(17)30340-X.
   Google Scholar
• Orchel J, Witek L, Kimsa M, et al. Expression patterns of kinin-dependent genes in endometrial cancer. Int J Gynecol Cancer. 2012;22(6):937–944.
   PubMed Web of Science ®Google Scholar
• Naidu N, Botha JH, Naidoo S. B1 but not B2 bradykinin receptor agonists promote DU145 prostate cancer cell proliferation and migration. Afr Health Sci. 2014;14(3):657–662.
   PubMed Web of Science ®Google Scholar
• Barki-Harrington L, Bookout AL, Wang G, et al. Requirement for direct cross-talk between B1 and B2 kinin receptors for the proliferation of androgen-insensitive prostate cancer PC3 cells. Biochem J. 2003;371(Pt 2):581–587.
   PubMedGoogle Scholar
• Taub JS, Guo R, Leeb-Lundberg LM, et al. Bradykinin receptor subtype 1 expression and function in prostate cancer. Cancer Res. 2003;63(9):2037–2041.
   PubMed Web of Science ®Google Scholar
• Molina L, Matus CE, Astroza A, et al. Stimulation of the bradykinin B(1) receptor induces the proliferation of estrogen-sensitive breast cancer cells and activates the ERK1/2 signaling pathway. Breast Cancer Res Treat. 2009;118(3):499–510.
   PubMed Web of Science ®Google Scholar
• Ehrenfeld P, Conejeros I, Pavicic MF, et al. Activation of kinin B1 receptor increases the release of metalloproteases-2 and −9 from both estrogen-sensitive and -insensitive breast cancer cells. Cancer Lett. 2011;301(1):106–118.
   PubMed Web of Science ®Google Scholar
• Noda M, Kariura Y, Amano T, et al. Expression and function of bradykinin receptors in microglia. Life Sci. 2003;72(14):1573–1581.
   PubMed Web of Science ®Google Scholar
• Ifuku M, Färber K, Okuno Y, et al. Bradykinin-induced microglial migration mediated by B1-bradykinin receptors depends on Ca2+ influx via reverse-mode activity of the Na+/Ca2+ exchanger. J Neurosci. 2007;27(48):13065–13073.
   PubMed Web of Science ®Google Scholar
• Austinat M, Braeuninger S, Pesquero JB, et al. Blockade of bradykinin receptor B1 but not bradykinin receptor B2 provides protection from cerebral infarction and brain edema. Stroke. 2009;40(1):285–293.
   PubMed Web of Science ®Google Scholar
• Raslan F, Schwarz T, Meuth SG, et al. Inhibition of bradykinin receptor B1 protects mice from focal brain injury by reducing blood-brain barrier leakage and inflammation. J Cereb Blood Flow Metab. 2010;30(8):1477–1486.
   PubMed Web of Science ®Google Scholar
• Bregola G, Varani K, Gessi S, et al. Changes in hippocampal and cortical B1 bradykinin receptor biological activity in two experimental models of epilepsy. Neuroscience. 1999;92(3):1043–1049.
   PubMed Web of Science ®Google Scholar
• Yasuyoshi H, Kashii S, Zhang S, et al. Protective effect of bradykinin against glutamate neurotoxicity in cultured rat retinal neurons. Invest Ophthalmol Vis Sci. 2000;41(8):2273–2278.
   PubMed Web of Science ®Google Scholar
• Mazzuferi M, Binaschi A, Rodi D, et al. Induction of B1 bradykinin receptors in the kindled hippocampus increases extracellular glutamate levels: a microdialysis study. Neuroscience. 2005;135(3):979–986.
   PubMed Web of Science ®Google Scholar
• Argañaraz GA, Silva JA Jr, Perosa SR, et al. The synthesis and distribution of the kinin B1 and B2 receptors are modified in the hippocampus of rats submitted to pilocarpine model of epilepsy. Brain Res. 2004;1006(1):114–125.
   PubMed Web of Science ®Google Scholar
• Rodi D, Buzzi A, Barbieri M, et al. Bradykinin B₂ receptors increase hippocampal excitability and susceptibility to seizures in mice. Neuroscience. 2013;248:392–402.
   PubMed Web of Science ®Google Scholar
• Duka A, Kintsurashvili E, Duka I, et al. Angiotensin-converting enzyme inhibition after experimental myocardial infarct: role of the kinin B1 and B2 receptors. Hypertension. 2008;51(5):1352–1357.
   PubMed Web of Science ®Google Scholar
• Hagiwara M, Murakami H, Ura N, et al. Renal protective role of bradykinin B1 receptor in stroke-prone spontaneously hypertensive rats. Hypertens Res. 2004;27:399–408.
   PubMed Web of Science ®Google Scholar
• Agata J, Miao RQ, Yayama K, et al. Bradykinin B1 receptor mediates inhibition of neointima formation in rat artery after balloon angioplasty. Hypertension. 2000;36:364–370.
   PubMed Web of Science ®Google Scholar
• Xu J, Carretero OA, Sun Y, et al. Role of kinin receptor in the regulation of cardiac function and remodeling after myocardial infarction. Hypertension. 2005;45(2):747–753.
   PubMedGoogle Scholar
• Desposito D, Potier L, Chollet C, et al. Kinin receptor agonism restores hindlimb postischemic neovascularization capacity in diabetic mice. J Pharmacol Exp Ther. 2015;352(2):218–226.
   PubMed Web of Science ®Google Scholar
• Desposito D, Zadigue G, Taveau C, et al. effect of kinin B1 receptor activation in acute cerebral ischemia in diabetic mine. Sci Rep. 2017;7(1):9410.
   PubMedGoogle Scholar
• Regoli D, Drapeau G, Rovero P, et al. The actions of kinin antagonists on B1 and B2 receptor systems. Eur J Pharmacol. 1986;123(1):61–65.
   PubMed Web of Science ®Google Scholar
• De Ligt RA, Kourounakis AP, IJzerman AP. Inverse agonism at G protein-coupled receptors: (patho)physiological relevance and implications for drug discovery. Br J Pharmacol. 2000;130(1):1–12.
   PubMed Web of Science ®Google Scholar
• Huey R, Bloor CM, Kawahara MS, et al. Potentiation of the anaphylatoxins in vivo using an inhibitor of serum carboxypeptidase N (SCPN). I. Lethalilty and pathologic effects on pulmonary tissue. Am J Pathol. 1983;112(1):48–60.
   PubMed Web of Science ®Google Scholar